Potassium%2525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCL) is an electrolyte replacement. It is essential for nerve impulse conduction, muscle contraction, and maintaining acid-base balance. ## Primary Indications * Treatment and prevention of hypokalemia. * Potassium supplementation in patients receiving potassium-depleting medications (e.g., diuretics). ## Adult Dosing * **Treatment of Hypokalemia:** * Oral: 20-100 mEq per day divided into 2-5 doses. Maximum 40 mEq per dose for standard formulations to minimize GI irritation. Higher doses may be used cautiously under close monitoring, especially in severe hypokalemia. * Intravenous (IV): Recommended rate is typically 10-20 mEq/hour. Maximum infusion rate generally 20 mEq/hour and maximum concentration 40 mEq/L (higher concentrations may be used in critical care settings with central venous access and continuous ECG monitoring, but this requires strict adherence to protocol). Daily doses typically range from 40-100 mEq, but can be higher based on severity and response. * **Prevention of Hypokalemia:** * Oral: 20-40 mEq per day divided into 1-2 doses. ## Pediatric Dosing * **Treatment of Hypokalemia:** * Oral: 2-5 mEq/kg/day divided into 2-4 doses. Maximum daily dose is typically 100 mEq. * Intravenous (IV): Similar to adults, infusion rate is generally limited to 0.5-1 mEq/kg/hour, not to exceed 20 mEq/hour. Maximum concentration typically 40 mEq/L. Daily dose depends on severity and electrolyte status, often ranging from 40-100 mEq/m^2/day. * **Prevention of Hypokalemia:** * Oral: 1-2 mEq/kg/day divided into 1-2 doses. *Note: Specific pediatric dosing may vary based on local institutional protocols and patient-specific factors.* ## Dose Adjustments * **Renal Impairment:** Dose reduction is necessary. Monitor potassium levels closely. Avoid in severe renal impairment if possible. * **Adrenal Insufficiency:** Increased risk of hyperkalemia. Dose adjustments are essential. ## Contraindications * Hyperkalemia. * Conditions causing potentially sustained high levels of potassium (e.g., untreated Addison's disease, severe renal impairment, anuria, oliguria). * Certain gastrointestinal obstructions or delays in transit. * Known hypersensitivity to potassium chloride. ## Adverse Effects * **Common:** Nausea, vomiting, diarrhea, abdominal pain, flatulence. * **Serious:** Hyperkalemia (muscle weakness, fatigue, paralysis, cardiac arrhythmias, cardiac arrest), esophageal or gastric irritation/perforation (especially with undissolved tablets or rapid infusion). ## Key Drug Interactions * **Potassium-Sparing Diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE Inhibitors and ARBs (e.g., lisinopril, losartan):** Increased risk of hyperkalemia. * **NSAIDs:** May decrease potassium excretion, increasing risk of hyperkalemia. * **Digoxin:** Hyperkalemia can increase digoxin toxicity; hypokalemia can increase digoxin toxicity. Maintain potassium within the normal range. * **Anticholinergics:** May increase GI absorption of potassium chloride tablets, potentially increasing risk of hyperkalemia. ## Monitoring * Serum potassium levels (frequently, especially with IV therapy or dose changes). * Renal function (BUN, creatinine). * ECG (especially with IV administration or suspicion of hyperkalemia). * Signs and symptoms of hypokalemia and hyperkalemia. ## Clinical Pearls * Oral potassium chloride tablets should be taken with meals or a full glass of water to minimize gastrointestinal upset and the risk of esophageal irritation. * Slow-release formulations are available and may reduce GI side effects but can be absorbed more slowly. * Intravenous potassium administration must be performed with caution, using an infusion pump, and with continuous cardiac monitoring when high doses or concentrations are used. Never administer IV potassium undiluted as a bolus injection. * Hypokalemia can be exacerbated by certain medications (e.g., loop and thiazide diuretics, amphotericin B, corticosteroids) and conditions (e.g., vomiting, diarrhea, hyperaldosteronism). *** *Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines for complete details and to verify dosing and safety information before administering any medication.*